期刊文献+

抗生素降阶梯治疗在糖尿病重症肺炎患者中的应用研究 被引量:10

Effects of de-escalation of antibiotic on diabetics with severe pneumonia
下载PDF
导出
摘要 目的分析抗生素降阶梯疗法在糖尿病重症肺炎患者中的临床应用效果。方法 30例糖尿病重症肺炎患者,随机分成抗生素降阶梯治疗组(A组18例)和常规升级组(B组12例),比较两组患者病死率、肺脏CT感染灶吸收率、抗生素使用时间、平均住院日、并发症控制时间及真菌定植发生率。结果 A组患者抗生素使用疗程、平均住院日较B组短(P<0.05),抗生素使用15d后病灶吸收率较B组高(P<0.05),病死率、真菌定植发生率较B组低(P<0.05)。结论抗生素降阶梯疗法治疗糖尿病重症肺炎患者具有控制感染迅速、病死率低、住院时间缩短等优点。 【Objective】To define effects of de-escalation of the antibiotic on diabetes with severe pneumonia. 【Methods】Thirty diabetics with severe pneumonia were divided into two groups randomly: group A (n=18) and B (n=12). Patients in group A received de-escalation of the antibiotic treatment and group B received conventional treatment. The two groups were compared by the use of antibiotics treatment, mortality and the incidence of fungal colonization, and so on.【Results】Length of antibiotic treatment and patient stay in group A was shorter than group B (P〈0.05), absorption of focus of infection was sooner than group B (P〈0.05), and mortality was significantly lower than group B (P〈0.05). Fungal colonization rate in group B was higher than the group A (P〈0.05).【Conclusion】 Choice of de-escalation of the antibiotic could improve significantly the prognosis of diabetics with severe pneu- monia.
作者 谢翠松
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第12期1869-1871,共3页 China Journal of Modern Medicine
关键词 抗生素 降阶梯治疗 糖尿病重症肺炎 antibiotic de-escalation diabetics with severe pneumonia
  • 相关文献

参考文献15

  • 1BENFIELD T, JENSEN JS, NORDESTGAARD BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome[J]. Diabetologia, 2007, 50(3): 549-554.
  • 2VENMANS LM, BONT J, GORTER KJ, et al. Prediction of complicated lower respiratory tract infections in older patients with diabetes[J]. Br J Cell Pract, 2008, 58(553): 564-568.
  • 3EHRLICH SF, QUESENBERRY CP JR, VAN DEN EEDEN SK, et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer [J]. Diabetes Care, 2010, 33 (1): 55-60.
  • 4BAKER EH, JANAWAY CH, PHILLPS B J, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease [J]. Thorax, 2006, 61(4): 284-289.
  • 5KOCH A, GRESSNER OA, SANSON E, et al. Serum resistin levels in critically in patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients[J]. Crit Care, 2009, 13(3): R95.
  • 6YOUNG F, CRITCHLEY JA, JOHNSTONE LK, et al. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization [J]. Global Health, 2009, 14: (5)1-9.
  • 7CHRISTIAN WEIGELT, BETTINA ROSE, ULRIKE POSCHEN, et al. Immune Mediators in Patients With Acute Diabetic Foot Syndrome[J]. Diabetes Care, 2009, 32(8): 1491-1496.
  • 8JI Q, MEI Y, WANG X, et al. Impact of diabetes mellitus on old patients undergoing coronary artery bypass grafting [J]. Int Heart J, 2009, 50(6): 693-700.
  • 9KORNUM JB, THOMSEN RW, RIIS A, et al. Type 2 diabetes and pneumonia outcomes: a population-based cohort study [J]. Diabetes Care, 2007, 30(9): 2251-2257.
  • 10VARDAKAS KZ, SIEMPOS II, FALAGAS ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality[J]. Diabet Med, 2007, 24(10): 1168-1171.

二级参考文献6

共引文献6

同被引文献90

引证文献10

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部